| IPAD-DB ID | C01306 | 
| Name | Galactosphingosine | 
| Category | Natural compounds | 
| 2D Structure | 
                             | 
                    
| 3D Structure | |
| Molecular Formula | C 2 4 H 4 7 N O 7 | 
| Molecular Weight | 461.6 g/mol | 
| IUPAC Name | (2R, 3R, 4S, 5R, 6R)-2-[(E, 2S, 3R)-2-amino-3-hydroxyoctadec-4-enoxy]-6-(hydroxymethyl)oxane-3, 4, 5-triol | 
| InChI | InChI=1S/C24H47NO7/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-19(27)18(25)17-31-24-23(30)22(29)21(28)20(16-26)32-24/h14-15, 18-24, 26-30H, 2-13, 16-17, 25H2, 1H3/b15-14+/t18-, 19+, 20+, 21-, 22-, 23+, 24+/m0/s1 | 
| InChIKey | HHJTWTPUPVQKNA-PIIMIWFASA-N | 
| Canonical SMILES | CCCCCCCCCCCCCC=CC(C(COC1C(C(C(C(O1)CO)O)O)O)N)O | 
| PubChem CID | 5280458 | 
| DrugBank Accession Number | - | 
| CAS Registry Number | 2238-90-6 | 
| Molecular Weight(Computed by SwissADME) | 461.63 | 
| Hac(Computed by SwissADME) | 32 | 
| Volume(Computed by ADMETlab 2.0) | 484.996 | 
| Density(Computed by ADMETlab 2.0) | 0.951 | 
| nRing(Computed by ADMETlab 2.0) | 1 | 
| MaxRing(Computed by ADMETlab 2.0) | 6 | 
| nHet(Computed by ADMETlab 2.0) | 8 | 
| fChar(Computed by ADMETlab 2.0) | 0 | 
| nRig(Computed by ADMETlab 2.0) | 7 | 
| Flexibility(Computed by ADMETlab 2.0) | 2.571 | 
| Stero Centers(Computed by ADMETlab 2.0) | 7 | 
| LogS(Computed by ADMETlab 2.0) | -2.452 | 
| LogD(Computed by ADMETlab 2.0) | 3.164 | 
| logP(Computed by ADMETlab 2.0) | 3.181 | 
| TPSA(Computed by SwissADME) | 145.63 | 
| Hbond Acceptor(Computed by SwissADME) | 8 | 
| Hbond Donor(Computed by SwissADME) | 6 | 
| Rotatable Bonds(Computed by SwissADME) | 18 | 
| GI Absorption(Computed by SwissADME) | Low | 
| BBB(blood-brain barrier) Permeant(Computed by SwissADME) | No | 
| P-gp Substrate(Computed by SwissADME) | Yes | 
| CYP1A2 Inhibitor(Computed by SwissADME) | No | 
| CYP2C19 Inhibitor(Computed by SwissADME) | No | 
| CYP2C9 Inhibitor(Computed by SwissADME) | No | 
| CYP2D6 Inhibitor(Computed by SwissADME) | No | 
| CYP3A4 Inhibitor(Computed by SwissADME) | No | 
| log Kp(Skin Permeation)(Computed by SwissADME) | -6.91 | 
| Lipinski(Computed by SwissADME) | 1 | 
| Ghose(Computed by SwissADME) | 1 | 
| Veber(Computed by SwissADME) | 2 | 
| Egan(Computed by SwissADME) | 1 | 
| Muegge(Computed by SwissADME) | 2 | 
| Bioavailability Score(Computed by SwissADME) | 0.55 |